Issued: January 2012.
Rituximab for the first-line treatment of stage III-IV follicular lymphoma : (review of NICE technology appraisal guidance 110) by National Institute for Health and Clinical Excellence. Published by National Institute for Health and Clinical Excellence in 2012. Publication and catalogue information, links to buy online and reader comments.